Clinical Trial Update: Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating dronedarone's impact on atrial fibrillation burden in patients with permanent pacemakers was terminated, and the results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED | Results posted: 2013-04-01